Cleopatra Hospital Company · EGX:CLHO

Cleopatra Hospital — Q1 2026 Earnings Presentation

60 slides from Cleopatra Hospital's earnings presentation, 2026

  1. Slide 1: Transforming Healthcare in Egypt

    Transforming Healthcare in Egypt Investor Presentation Q1 2026

  2. Slide 2: Disclaimer

    Disclaimer This presentation contains forward-looking statements, including, but not limited to, statements concerning expectations, projections, objectives, targets, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs, plans or intentions relating

  3. Slide 3: Contents

    CONTENTS 1 Cleopatra Hospitals Group Highlights 2 Macro Environment 3 Competitive Advantages 4 Growth Strategy & New Business 5 Governance & Management Information 6 Q1 2026 in Review 7 Appendix

  4. Slide 4: Cleopatra Hospitals Group Highlights

    Cleopatra Hospitals Group Highlights 4

  5. Slide 5: CHG Mission, Vision and Values

    CHG Mission, Vision and Values ➢ A Patient-First Approach to Healthcare Our Mission • Delivering Leading Quality Services • Ensuring Safety of all Stakeholders • Growing Beds Supply & Expanding their Distribution • Improving Quality of Lives Everyday ➢ Sustainable Growth & Cross-Asset Collaboration

  6. Slide 6: Broad Network Across Greater Cairo and Beyond

    Broad Network Across Greater Cairo and Beyond, Penetrating Underserved Regions Leveraging a growing footprint, CHG continues to penetrate new segments of the population and provide high quality care to underserved regions across Greater Cairo Leveraging a growing footprint, CHG continues to penetrat

  7. Slide 7: Cementing Impact Today & Scaling for the Future

    Cementing Impact Today & Scaling for the Future Performance Progression (EGP mn) CAGR 2015-2019 2019-2022 2022-2025 Revenue 45% 13% 40% Gross Profit 45% 12% 48% EBITDA 41% 12% 44% Net Profit 40% 10% 39% Institutionalization and Building the Foundation Agile Business Model Business Leverage 8,000 7,2

  8. Slide 8: Record Breaking Results for Q1 2026

    Record Breaking Results for Q1 2026 The Group reported consolidated Q1 2026 Snapshot revenues of EGP 1,973mn in the first quarter of 2026, up 22% year- on-year from the EGP 1,619mn recorded in Q1 2025. This top-line EGP 1,973 mn EGP 645 mn growth was driven by the addition Consolidated revenues in Q

  9. Slide 9: Fast Growing, Diversified Healthcare Services Provider

    Fast Growing, Diversified Healthcare Services Provider Group Revenue, EBITDA and Margins | EGP mn Revenue CAGR:  25% 7,227 5,420 1,973 29.6% 1,619 3,595 28.2% 2,137 30.8% 25.2% 1,181 29.9% 26.5% 27.9% 27.1% 2,549 29.9% 2,614 27.1% 1,529 498 497 354 1,798 502 1,990 540 763 709 954 2019 2020 2021 202

  10. Slide 10: Macro Environment

    Macro Environment 10

  11. Slide 11: Growing Population & Prevalence of Lifestyle Diseases

    Growing Population & Prevalence of Lifestyle Diseases Demographics Common Illnesses Breast Cancer Cases Communicable Diseases Lung Cancer Cases CAGR 3% 382,642 Cases CAGR 3% Acute Respiratory illness 33,863 Cases Chicken Pox 7,521 Cases 23,081 40,544 11,945 Brucella 6,045 2018 2040 2018 2040 • The m

  12. Slide 12: Egypt’s Healthcare Market Structure

    Egypt’s Healthcare Market Structure Hospitals by Governorate and Geographical Disparities Medical Services in the Region EGYPT GCC MENA • Healthcare facilities are highly • Doctor/1,000 population ratio for concentrated in Cairo, Alexandria, Egypt is higher than both MENA Daqahleya & Giza which toge

  13. Slide 13: Healthcare Investments in Egypt

    Healthcare Investments in Egypt Private Sector as a % of total Healthcare Expenditure (2023) Government Spending 62% Government Healthcare Expenditure % of Total Expenditure 56% 58% 6.8% 4.7% 4.8% 5.2% 40% 39% 34% 36% 23% 21% 2018 2019 2020 2021 15% • Egypt’s House of Representatives approved budget

  14. Slide 14: Competitive Advantages

    P 7, -e . ae >» _ Benpstve 4 lam end = vantages

  15. Slide 15: A leading healthcare services platform with sustainable competitive advantages

    A leading healthcare services platform with sustainable competitive advantages CHG was a pioneering force in Egypt's private healthcare sector, recognizing its potential early on. The Group introduced an innovative 360-degree integrated management system, focused on delivering quality patient care a

  16. Slide 16: CHG’s Centers of Excellence are built on key pillars

    CHG’s Centers of Excellence are built on key pillars that drive consistent, high-quality performance Defining Centers of Excellence Select Examples of CHG’s Centers of Excellence Competitive Defined Scope & Nursing & Residents Advantage & Sales Focus Team Differentiation Consumables Medical Equipmen

  17. Slide 17: Growth Strategy & New Business

    Growth Strategy & New Business 17

  18. Slide 18: Core growth strategy – Driving sustainable expansion and value creation

    CHG advances its strategic agenda through a clearly defined core growth strategy – Driving sustainable expansion and value creation Integrating the platform to Leveraging payor and achieve higher efficiencies supplier relationships Geographic expansion in Egypt Enhancing utilization and linked to fo

  19. Slide 19: 2026 Strategy: Foundation For Sustainable Growth & Financial Strength

    2026 Strategy: Foundation For Sustainable Growth & Financial Strength Pricing to Follow Inflation Leverage Trends Maintain on Organic Competitive Hospitals Edge Deleverage Enhanced Cash Minimum Capex & Maintain Conversion Cycle Capital Invest minimal capex in 2026 limited to the Framework 1) Higher

  20. Slide 20: Expanding West Cairo: Cleopatra October Hospital

    Expanding West Cairo: Cleopatra October Hospital – CHG’s Flagship Asset Facility Overview Cleopatra October Current Facility + Extension Building • Transformed by CHG into a world-class tertiary hospital specialized in orthopedics, spine, rehabilitation & sports injuries (largest COEs in Egypt & MEN

  21. Slide 21: Cleopatra El-Tagamoa Hospital

    Strengthening Presence in Underserved Regions: Cleopatra El-Tagamoa Hospital • In line with CHG’s strategy to expand into underserved regions, the Group launched a top-tier hospital in East Cairo and introduced 240 new beds to the market starting end of 2025. • Operates under an asset-light, 25-year

  22. Slide 22: Cleopatra El-Tagamoa Hospital: Grand Inauguration

    Cleopatra El-Tagamoa Hospital: Grand Inauguration with Egypt’s National Leadership The Prime Minister witnesses the inauguration of Cleopatra El-Tagamoa Hospital, a milestone in public private partnership and advanced medical care. 22

  23. Slide 23: The Grand Inauguration: Entrances

    The Grand Inauguration of Cleopatra El-Tagamoa Hospital Entrances 23

  24. Slide 24: The Grand Inauguration: Reception Atrium

    The Grand Inauguration of Cleopatra El-Tagamoa Hospital Reception Atrium 24

  25. Slide 25: The Grand Inauguration: CHG Academy and Auditorium

    The Grand Inauguration of Cleopatra El-Tagamoa Hospital CHG Academy and Auditorium 25

  26. Slide 26: The Grand Inauguration: Emergency Room, Outpatient Clinics

    The Grand Inauguration of Cleopatra El-Tagamoa Hospital Emergency Room Outpatient Clinics Pharmacy OPD 26

  27. Slide 27: The Grand Inauguration: Operating Room, Inpatient Room

    The Grand Inauguration of Cleopatra El-Tagamoa Hospital Operating Room Inpatient Room 27

  28. Slide 28: The Grand Inauguration: Pharmacy, Dialysis

    The Grand Inauguration of Cleopatra El-Tagamoa Hospital Pharmacy Dialysis 28

  29. Slide 29: The Grand Inauguration: Dentistry, CCU

    The Grand Inauguration of Cleopatra El-Tagamoa Hospital Dentistry CCU 29

  30. Slide 30: Launch of Maadi Polyclinics

    Launch of Maadi Polyclinics as a referral hub for Nile Badrawi Hospital Description: • A multi-specialty polyclinic facility with 30 clinics, with diagnostics & physiotherapy services • Launched in February 2026 Scope: • Expand and increase the market share of CHG in Maadi & Mokattam areas. • Increa

  31. Slide 31: Governance & Management Information

    Governance & Management Information 31

  32. Slide 32: Best-in-class corporate governance standards

    CHG employs best-in-class corporate governance standards that are in line with the highest international standards… OPERATIONS ABC No Referral Fees Medical Council • CHG has a zero-tolerance approach to bribery and • CHG does not pay any referral fees or kickbacks to • CHG recently launched a group-

  33. Slide 33: Board of directors

    … supported by a board of directors dominated by experienced independent and non- executive directors and focused on growing shareholder value… The Group’s Board of Directors provide the necessary oversight and combination of expertise to thoroughly oversee the Group’s corporate governance framework

  34. Slide 34: Highly competent management team

    … and led by a highly competent and ambitious management team comprised of accomplished industry veterans with vast experience in the healthcare sector The Group is managed by a seasoned team that brings along deep industry experience to their respective positions gained in leading regional and mult

  35. Slide 35: Q1 2026 in Review

    Q1 2026 in Review 35

  36. Slide 36: Our Strategy drives consistent long-term value

    Our Strategy drives consistent long-term value Cases Outpatient Inpatients Surgeries Revenues Served Visits 3 Year CAGR: 3 Year CAGR: 3 Year CAGR: 3 Year CAGR: 3 Year CAGR: 12.4% 10.8% 15.2% 5.0% 40.3% Q1 2026: Q1 2026: Q1 2026: Q1 2026: Q1 2026: 355,035 17,508 289,368 9,301 EGP 1,973mn Y-o-Y Growth

  37. Slide 37: Q1 2026 Financial Performance Overview

    Q1 2026 Financial Performance Overview Q1 2026 Snapshot ▪ CHG sustained its top-line growth trajectory in Q1 2026, generating consolidated revenues of EGP 1,973mn, representing a 22% year-on-year increase from EGP 1,619mn in 1Q2025. This performance marks a continuation of the robust growth delivere

  38. Slide 38: Core Business Driven Growth

    Core Business Driven Growth Volume, ARP, & Revenue | Volume, ARP, & Revenue | Volume, ARP, & Revenue | Surgeries Outpatients Laboratory Rev. in EGP Mn. Vol. In 000’ Rev. in EGP Mn. Vol. In 000’ Rev. in EGP Mn. EGP 29,792 EGP 34,254 EGP 535 EGP 311 EGP 380 12,0 00 500 350 EGP 549 180 600 250 450 160

  39. Slide 39: Balance Sheet Highlights

    Balance Sheet Highlights CAPEX Profile and Cash Flow Highlights ▪ Capex & CTH Transition ▪ Q1 2026 capex centered on medical equipment and fit-out at Cleopatra El Tagamoa Hospital (CTH) ▪ Payments under capital commitments (PUC): EGP 421mn vs EGP 607mn in Q1 2025 ▪ Decline reflects CTH's shift from

  40. Slide 40: CLHO.CA Share Performance

    CLHO.CA Share Performance CHG’s Price Performance | Rebased to 100 Valuation Multiples 1 Month VWAP Closing June 16th 20 15.89 15.59 12.4x 10.3x 18 8.0x 7.6x 7.9x 16 EV/EBITDA Valuation 14 Multiples (x) Volume (mn) 12 10 FY 2022 FY 2023 FY 2024 FY 2025 Q1 2026 8 6 23.8x 20.7x 4 14.0x 13.8x 12.2x 2 P

  41. Slide 41: Appendix: Financial Statements

    Appendix: Financial Statements 41

  42. Slide 42: Consolidated Income Statement

    Consolidated Income Statement Income Statement | EGP mn 1Q2025 1Q2026 % Change Revenues 1,618.7 1,972.5 21.9% Cost of sales (1,004.4) (1,327.9) 32.2% Gross profit 614.3 644.6 4.9% Gross Profit Margin 37.9% 32.7% General & administrative expenses (262.7) (358.5) 36.5% Cost of acquisition activities (

  43. Slide 43: Consolidated Balance Sheet

    Consolidated Balance Sheet Balance Sheet | EGP mn a 31 December 2025 31 March 2026 Non-current assets Fixed assets 7,072.9 7,391.5 Intangible assets 403.2 402.7 Right of use 132.9 125.0 Revenue Share Down Payment 250.3 241.6 Investment in associates 18.6 18.6 Total non-current assets 7,877.9 8,179.3

  44. Slide 44: Consolidated Cash Flow Statement

    Consolidated Cash Flow Statement Cash Flow Statement | EGP 31 March 2025 31 March 2026 Cash flow from operating activities: Profit before tax 321.2 219.2 Adjustments for: Depreciation 50.2 118.4 Amortization of intangible assets 0.5 0.5 Allowance for impairment of current assets 34.6 34.4 Provision

  45. Slide 45: Appendix: Photo Library

    Appendix: Photo Library 45

  46. Slide 46: Cleopatra Hospital

    CHG Cleopatra Hospital 46

  47. Slide 47: Cairo Specialized Hospital

    Cairo Specialized Hospital 47

  48. Slide 48: Nile Badrawi Hospital

    | Nile Badrawi Hospital 48

  49. Slide 49: Al Shorouk Hospital

    CHG Al Shorouk Hospital 49

  50. Slide 50: Cleopatra October Hospital

    Cleopatra October Hospital 50

  51. Slide 51: Cleopatra El Tagamoa Hospital

    Cleopatra El Tagamoa Hospital 51

  52. Slide 52: El Katib Hospital

    El Katib Hospital 52

  53. Slide 53: Bedaya Hospital

    Bedaya Hospital 53

  54. Slide 54: Cleopatra Clinics (East Cairo)

    Cleopatra Clinics (East Cairo) 54

  55. Slide 55: Cleopatra Clinics (West Cairo)

    Cleopatra Clinics (West Cairo) 55

  56. Slide 56: Cleopatra Clinics (Maadi)

    Cleopatra Clinics (Maadi) 56

  57. Slide 57: Cleopatra Clinics (Mohandesin / Al Shorouk Hospital)

    Cleopatra Clinics (Mohandesin / Al Shorouk Hospital) 57

  58. Slide 58: Cleopatra Clinics (Suez Governorate)

    Cleopatra Clinics (Suez Governorate) 58

  59. Slide 59: Cleopatra Clinics (Pyramids Clinic)

    Cleopatra Clinics (Pyramids Clinic) 59

  60. Slide 60: Thank you

    Thank you INVESTOR RELATIONS CONTACTS SHAREHOLDER INFORMATION ir@cleohc.com Email: ir@cleohc.com https://www.cleopatrahospitals.com/en/investors/ EGX: CLHO.CA Website: https://www.cleopatrahospitals.com/en/investors/ Listed: June 2016 Shares Outstanding: 1.4 billion 60

Cleopatra Hospital Company — Q1 2026 Earnings Presentation on 6ix